PPARA and glioblastoma: The PPARα antagonist AA452 downregulates the expression of c-Myc, cyclin D1, p-FAK, COX2, and pERK1/2 in glioblastoma primary cells, blocks cell proliferation, and increases sensitivity to radiotherapy [100].